Visualizing Digital Healthcare Data

It is no surprise that communications strategies that drive meaningful changes in health outcomes need to be heavily grounded in up-to-date research. Increasingly that research focuses on digital health information as health-related queries continue to dominate Google searches and patients becoming increasingly comfortable sharing personal health information online. In many cases, we are researching everything from conversation trends to social sharing to web traffic to get a better understanding of how our clients can strategically tailor their messages. Besides using this data to inform messaging strategies, another major opportunity that...

The (New) Ethics of Medical Privacy

I recently had the opportunity to attend a screening of Here.Us.Now., a documentary funded by the Ewing Marion Kauffman Foundation. It should be required viewing for anyone who touches the health care system, which includes pretty much everyone. The film tells the story of Chris and Hugh Hempel’s medical odyssey in the wake of their twin daughters’ diagnosis with a rare, incurable disease called Niemann-Pick Type C. I can’t get this film out of my head.   Why? Because it not only tells the Hempels’ story rationally and beautifully, it uses their narrative to absolutely nail the bigger issues facing any family desperately...

Creating a New Class of Vaccines

Vaccines are among the most cost-effective and successful health interventions ever developed, saving millions of lives each year. However, traditional vaccines are designed to target pathogens that live in the bloodstream. Many infectious diseases, such as herpes, chlamydia and malaria, live inside the body’s cells, leaving these serious illnesses literally beyond the reach of available technology—until now. Genocea Biosciences, an FKH client,  is working to develop the first vaccine that will trigger the body to destroy its own infected cells –something that has never before been possible, due to the volume of potential pathogen T...

Here. Us. Now: Documentary Spotlights Rare Disease

Recently, members of Feinstein Kean’s Cambridge staff gathered for a screening of the documentary Here. Us. Now. The film shares the inspirational story of two parents who receive a crash course in drug development. Hugh and Chris Hempel of Reno, NV were forced into the world of rare diseases when their twin daughters, Addison and Cassidy, were diagnosed with Niemann-Pick Type C (NPC1), a terminal disease affecting only an estimated 1 in 150,000 people worldwide. NPC1 is caused by a genetic mutation involving lipid metabolism and eventually leads to fatal build-up of lipids in the brain. This causes developmental delays and leads to...